(1 - 20 von 35
)
UBC professor uses knowledge of SARS to develop COVID-19 drug |...
globalnews.ca
Dr. Josef Penninger, a UBC life sciences institute director, co-discovered an enzyme called ACE2 while working as a researcher in Toronto in the late 90s.
Lab-grown mini human organs may play key role in COVID-19 drug ...www.deccanherald.com › science-and-environment
www.deccanherald.com
· ... which closely resemble human tissues that are relevant for disease,” Josef Penninger, Director, Life Science Institute at the University of.
Promising trial drug blocks early stages of COVID-19 •...
healthcare-in-europe.com
An international team led by University of British Columbia (UBC) researcher Dr. Josef Penninger has found a trial drug that effectively blocks the cellular door SARS-CoV-2 uses to infect its hosts. The findings, published in Cell, hold promise as a treatment capable of stopping early infection of the novel coronavirus that, as of April 2, has affected more than 981,000 people and claimed the ...
Alter Sars-Wirkstoff wird jetzt gegen Covid-19 getestet: Die Stacheln...
www.tagesspiegel.de
Der Wiener Forscher Josef Penninger forscht damals an Sars-CoV-1, ... die auf elektronenmikroskopischen Bildern wie eine Krone oder eine ...
sortiert nach Relevanz / Datum